Copyright
©The Author(s) 2023.
World J Gastroenterol. Jun 14, 2023; 29(22): 3385-3399
Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3385
Published online Jun 14, 2023. doi: 10.3748/wjg.v29.i22.3385
Test
| Abbreviation | Sensitivity | Specificity | Turn-around time | Target substance |
Culture-based | |||||
Cell cytotoxicity neutralisation assay | CCTN | High | High | < 24 h | Toxins |
Toxigenic culture | TC | High | Low1 | > 3 d | C. difficile vegetative cells or spores |
DNA-based | |||||
Nucleic acid amplification test2 | NAAT | High | Low/moderate | < 4 h | Toxin genes |
Protein-based | |||||
Glutamate dehydrogenase | GDH-EIA | High | Low1 | < 2 h | C. difficile antigens |
Toxin A and B enzyme immunoassays | EIA | Low | Moderate | < 2 h | Toxins |
- Citation: Bocchetti M, Ferraro MG, Melisi F, Grisolia P, Scrima M, Cossu AM, Yau TO. Overview of current detection methods and microRNA potential in Clostridioides difficile infection screening. World J Gastroenterol 2023; 29(22): 3385-3399
- URL: https://www.wjgnet.com/1007-9327/full/v29/i22/3385.htm
- DOI: https://dx.doi.org/10.3748/wjg.v29.i22.3385